»ó´Ü¿©¹é
±â»ç (Àüü 947°Ç)
[Conference Report] ±¹³» ȯÀÚ ´ë»ó MET + DPP-4i + SGLT-2i º´¿ë¿ä¹ý ±Ù°Å Á¦½Ã ÀÓ¼¼Çü ±âÀÚ 2023-07-05 14:31
[Conference Report] ÆéŸÀÌµå ±â¹Ý Ä¡·áÁ¦ °æÀï ´õ Ä¡¿­ÇØÁø´Ù ÀÓ¼¼Çü ±âÀÚ 2023-07-05 14:28
[Conference Report] ReDM SEOUL 2023 SYMPOSIUM ÀÓ¼¼Çü ±âÀÚ 2023-07-03 16:17
[Interview] Æø³ÐÀº 2Çü´ç´¢º´ ȯÀÚ¿¡¼­ ÇýÅà ±â´ë ÀÓ¼¼Çü ±âÀÚ 2023-06-05 14:51
[Interview] ¡°SGLT-2i/TZD, ´Ù¸¥ ±âÀüÀÇ Á¶ÇÕÀ¸·Î ½Ã³ÊÁö È¿°ú ±â´ë¡± ÀÓ¼¼Çü ±âÀÚ 2023-06-05 14:18
¶óÀÎ
[Sub Story] Ç÷´çÁ¶Àý¿¡¼­ ½É³úÇ÷°üÁúȯ¡¤NAFLD±îÁö ÀÓ¼¼Çü ±âÀÚ 2023-06-05 13:24
[Interview] ´ç´¢º´ ȯÀÚÀÇ ³úÁ¹Áß °ü¸® À§ÇÑ È¿À²Àû ¹æ¾È ÀÓ¼¼Çü ±âÀÚ 2023-06-05 13:16
[Sub Story] Ç÷´çº¯µ¿¼º¡¤ÀúÇ÷´çÁõ À§Çè°ü¸® °¡´ÉÇÑ Ç÷´ç°üÂû Àü·« ÀÓ¼¼Çü ±âÀÚ 2023-06-05 13:02
[Interview] ¡°´ÙȸÀν¶¸°ÁÖ»ç¿ä¹ý ȯÀÚ, °ü¸® ½Ã½ºÅÛ ºÎÀçÇÏ´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2023-06-05 12:59
[Interview] ¡°½ºÅ¸Æ¾ ´Üµ¶¿ä¹ý ÀÌ»óÁöÁúÇ÷Áõ °ü¸®ÀÇ ½ÃÀÛ¡± ÀÓ¼¼Çü ±âÀÚ 2023-05-04 16:45
¶óÀÎ
[Interview] ¡°ÀþÀº ¼ºÀκÎÅÍ Àû±ØÀûÀ¸·Î LDL-C °ü¸®Çؾߡ± ÀÓ¼¼Çü ±âÀÚ 2023-05-04 16:24
[Deep in Guideline] ±¹³» °íÇ÷¾Ð ¸ÂÃãÄ¡·á, Ç÷¾ÐºÐ·ùºÎÅÍ ½ÃÀÛ ÀÓ¼¼Çü ±âÀÚ 2023-05-04 14:20
[Interview] ¡°¿ì¼öÇÑ È¿°ú¿Í ¾ÈÀü¼ºÀ¸·Î ½Ã³ÊÁö ±â´ëÇÒ ¼ö ÀÖ´Â À§¿° Ä¡·áÁ¦¡± ÀÓ¼¼Çü ±âÀÚ 2023-05-04 10:58
[Drug Review] ¿¡¼Òµà¿À¿¡½º, Á¦ÇüÅ©±â ´õ ÁÙÀÎ ¼Ó¹æÇü ¿¡½º¿À¸ÞÇÁ¶óÁ¹ ÀÓ¼¼Çü ±âÀÚ 2023-05-04 10:47
[Conference Report] ReDM BUSAN 2023 SYMPOSIUM ÀÓ¼¼Çü ±âÀÚ 2023-05-04 10:43
¶óÀÎ
[Cover Story] È£Èí±âÁúȯ °ü¸®Àü·« ÆÛÁñ ´Ù½Ã ¸ÂÃçÁ³´Ù ÀÓ¼¼Çü ±âÀÚ 2023-04-03 18:27
[Sub Story] GOLD ȯÀÚ±º ÀçÆí LABA + LAMA Àü·« ´ëµÎ ÀÓ¼¼Çü ±âÀÚ 2023-04-03 18:18
[Interview] ¡°±¹³» COPD Áø·áÁöħ°ú ¹æÇ⠸¾Ҵ١± ÀÓ¼¼Çü ±âÀÚ 2023-04-03 18:12
[Sub Story] LABA, COPD Ä¡·áÀÇ ÁÖ¿ä ±â°üÁöÈ®ÀåÁ¦ ÀÓ¼¼Çü ±âÀÚ 2023-04-03 17:59
[Sub Story] ¡®LABA/LAMA¡¯, COPD °ü¸® ÇÙ½ÉÀü·«À¸·Î ÀÓ¼¼Çü ±âÀÚ 2023-04-03 17:56
Back to Top